Tag: cardiomyopathy

FDA Approves Vutrisiran to Treat ATTR-CM- New Treatment Seeks to Minimize Risks of Heart Failure in Patients.

FDA approval Vutrisiran ATTR-CM treatment for the treatment of transthyretin amyloid cardiomyopathy (ATTR-CM) in adults This is a significant milestone...